Idiopathic pulmonary fibrosis (IPF) is a progressive fibroproliferative disorder with poor prognosis and generally ineffective therapy. A clearer understanding of the pathobiological processes leading to IPF has emerged over the last several years. This has led to efforts for generating targeted, novel, therapeutic approaches that translate these mechanistic observations from the bench to clinically relevant therapeutic trial. Three separate sentinel findings made at our institution have resulted in active therapeutic trials. These include: 1) an imbalance of leukotriene production in the lungs of IPF patients;2) inhibition of TGF-B production by the copper binding agent, tetrathyomolybdate (TM), ameliorates bleomycin induced fibrosis;and 3) the surgical lung biopsies and fibroblasts isolated from the lungs of IPF patients exhibit skewed cytokine transcript expression toward IL-13 and its receptors. We have designed three phase I or phase II clinical therapeutic trials based on these observations. These include: 1) a phase II randomized controlled trial of a 5-lipoxygenase inhibitor, zileuton, versus standard therapy with azathioprine and prednisone in IPF;2) a phase II safety/efficacy study of TM in advanced IPF;and 3) a phase I study assessing safety of a unique, IL-13-pseudomonas exotoxin chimeric molecule that targets fibroblasts in the lungs of IPF patients. The candidate for this award has extensive experience in patient-oriented research and has short and longterm goals of developing the expertise and creating the infrastructure required to form a critical nucleus of patient-oriented researchers that can optimally design and conduct clinically relevant therapeutic trials in this devastating disease. This process will create an optimal, comprehensive training environment for investigators that express an interest in patient-oriented research that carries forth molecular observations of disease pathogenesis into viable therapies. This will become particularly important if translational research is to keep pace as strides are made in the basic immunology, genetics and biochemistry of IPF.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
5K24HL004212-10
Application #
7576778
Study Section
Special Emphasis Panel (ZHL1-CSR-Q (O1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2000-03-02
Project End
2010-02-28
Budget Start
2009-03-01
Budget End
2010-02-28
Support Year
10
Fiscal Year
2009
Total Cost
$84,747
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Freeman, Christine M; Martinez, Carlos H; Todt, Jill C et al. (2015) Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood. Respir Res 16:94
Freeman, Christine M; Stolberg, Valerie R; Crudgington, Sean et al. (2014) Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease. PLoS One 9:e103840
Freeman, Christine M; McCubbrey, Alexandra L; Crudgington, Sean et al. (2014) Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent. PLoS One 9:e96421
Freeman, Christine M; Martinez, Fernando J; Han, Meilan K et al. (2013) Lung CD8+ T cells in COPD have increased expression of bacterial TLRs. Respir Res 14:13
Schmidt, S L; Nambiar, A M; Tayob, N et al. (2011) Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 38:176-83
Han, MeiLan K; Swigris, Jeffrey; Liu, Lyrica et al. (2010) Gender influences Health-Related Quality of Life in IPF. Respir Med 104:724-30
Giardino, Nicholas D; Curtis, Jeffrey L; Andrei, Adin-Cristian et al. (2010) Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res 11:29
Fell, Charlene D; Martinez, Fernando J; Liu, Lyrica X et al. (2010) Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 181:832-7
Han, M K; Wise, R; Mumford, J et al. (2010) Prevalence and clinical correlates of bronchoreversibility in severe emphysema. Eur Respir J 35:1048-56
Schneider, Dina; Ganesan, Shyamala; Comstock, Adam T et al. (2010) Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182:332-40

Showing the most recent 10 out of 37 publications